{"id":"W2049816046","doi":"10.1097/00002826-200201000-00005","title":"A Double-Blind Crossover, Placebo-Controlled Study of the Adenosine A2A Antagonist Theophylline in Parkinson's Disease","year":2002,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Theophylline; Crossover study; Antagonist; Placebo; Medicine; Adenosine; Double blind; Anesthesia; Pharmacology; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004383747,0.0002470698,0.0005458399,0.000056884,0.0001082175,0.00001794095,0.0005662713,0.0001584663,0.0002431556],"category_scores_gemma":[0.0003968016,0.0001768114,0.0002836684,0.0002442059,0.0003042732,0.000005192579,0.0003393918,0.0004235373,0.00001447878],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007467981,"about_ca_system_score_gemma":0.00005934683,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001511128,"about_ca_topic_score_gemma":0.00001135276,"domain_scores_codex":[0.9971356,0.000764849,0.0009628367,0.0006102864,0.000185476,0.0003409444],"domain_scores_gemma":[0.998543,0.0003464696,0.0003354673,0.0005182953,0.00008683596,0.0001699526],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4300059,0.02224407,0.4154112,0.0000883508,0.0007980834,0.000893274,0.0002827589,0.00437121,0.08321408,0.0001034728,0.04162463,0.0009628993],"study_design_scores_gemma":[0.7407561,0.006892849,0.1344079,0.0000436288,0.001005494,0.00004684579,0.0001627407,0.004426963,0.01119981,0.00008600828,0.09987011,0.001101569],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948335,0.00181947,0.000006570435,0.000813963,0.0009017464,0.00133864,0.00001349794,0.00001180781,0.0002608239],"genre_scores_gemma":[0.9957277,0.0005893266,0.000009585907,0.001644766,0.0007303516,0.0001086168,0.000007230059,0.00003335275,0.001149109],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3107502,"threshold_uncertainty_score":0.7210158,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05653257955031033,"score_gpt":0.3572882097378645,"score_spread":0.3007556301875541,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}